| Market Capitalization (Millions $) |
- |
| Shares
Outstanding (Millions) |
119 |
| Employees |
434 |
| Revenues (TTM) (Millions $) |
115 |
| Net Income (TTM) (Millions $) |
-41 |
| Cash Flow (TTM) (Millions $) |
5 |
| Capital Exp. (TTM) (Millions $) |
1 |
Business Description
Sequenom Inc. is a life science company that specializes in genetic analysis products and services for research and clinical applications. Founded in 1994, Sequenom is headquartered in San Diego, California.
Sequenom develops and sells products and services that enable the analysis and understanding of genetic information. Their product portfolio includes genetic testing services, genotyping assays, and mass spectrometry systems. The company primarily focuses on applications in prenatal diagnosing, oncology, and pharmacogenomics.
The company's flagship product is the MaterniT21 Plus prenatal test, which uses non-invasive prenatal screening (NIPS) to detect genetic disorders in a fetus. This test is used to identify chromosomal abnormalities like Down syndrome and has a higher accuracy rate than traditional screening methods. The MaterniT21 Plus test is the first commercially available NIPS test for all pregnant women.
Sequenom also offers a range of genotyping assays that enable researchers and clinicians to study genetic variation. Their MassARRAY System uses mass spectrometry technology to provide highly accurate and reproducible genotyping results, making it a popular choice in the research community.
In addition to their product offerings, Sequenom has a services arm that provides genetic testing services. The company provides testing services for prenatal, inherited disorders, and oncology using advanced genetic testing technologies.
Sequenom has established strong partnerships with academic institutions, pharmaceutical companies, and healthcare providers to develop and commercialize genetic testing products and services. The company has several collaborations and partnerships with leading healthcare companies and academic institutes worldwide.
Overall, Sequenom is a leading genetic analysis company that offers innovative products and services for research and clinical applications. The company's commitment to research and development, partnerships, and customer-centric approach has positioned them as a trusted provider of genetic testing solutions.
|
%